Recce Pharmaceuticals Ltd (RCE) - Total Liabilities

Latest as of December 2025: AU$20.66 Million AUD ≈ $14.62 Million USD

Based on the latest financial reports, Recce Pharmaceuticals Ltd (RCE) has total liabilities worth AU$20.66 Million AUD (≈ $14.62 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Recce Pharmaceuticals Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Recce Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. See RCE working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Recce Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Recce Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Markforged Holding Corp NYSE:MKFG	USA	$82.41 Million
Pasofino Gold Limited V:VEIN	Canada	CA$28.51 Million
Favelle Favco Bhd KLSE:7229	Malaysia	RM624.09 Million
Papaya Growth Opportunity Corp I NASDAQ:PPYA	USA	$24.32 Million
Rand Mining Ltd AU:RND	Australia	AU$6.63 Million
HLS Therapeutics Inc TO:HLS	Canada	CA$75.72 Million
NCS Multistage Holdings Inc NASDAQ:NCSM	USA	$34.91 Million
Creepy Jar SA WAR:CRJ	Poland	zł17.86 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Recce Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Recce Pharmaceuticals Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.08	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	10.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Recce Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Recce Pharmaceuticals Ltd (2013–2025)

The table below shows the annual total liabilities of Recce Pharmaceuticals Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$15.47 Million ≈ $10.94 Million	-2.69%
2024-06-30	AU$15.89 Million ≈ $11.25 Million	+208.93%
2023-06-30	AU$5.14 Million ≈ $3.64 Million	+100.79%
2022-06-30	AU$2.56 Million ≈ $1.81 Million	+117.54%
2021-06-30	AU$1.18 Million ≈ $833.38K	+26.44%
2020-06-30	AU$931.53K ≈ $659.11K	-29.84%
2019-06-30	AU$1.33 Million ≈ $939.49K	+195.84%
2018-06-30	AU$448.82K ≈ $317.57K	-48.67%
2017-06-30	AU$874.44K ≈ $618.72K	+322.85%
2016-06-30	AU$206.80K ≈ $146.32K	-24.10%
2015-06-30	AU$272.47K ≈ $192.79K	+33.69%
2014-06-30	AU$203.81K ≈ $144.21K	+31.86%
2013-06-30	AU$154.57K ≈ $109.37K	--

About Recce Pharmaceuticals Ltd

AU:RCE Australia Biotechnology

Market Cap

$98.22 Million

AU$138.81 Million AUD

Market Cap Rank

#19307 Global

#624 in Australia

Share Price

AU$0.48

Change (1 day)

+0.00%

52-Week Range

AU$0.29 - AU$0.71

All Time High

AU$1.68